In CRC, tumor buds showed lower nuclear Ki-67 levels (i.e., lower proliferation) and higher nuclear p16INK4, cyclin D1, and β-catenin levels [126,127,128], as compared to the main tumor mass [126,127]. Here, CDKN2A is linked to neoplasm.